Lunai Bioworks Inc. (LNAI) Stock Analysis
Over the past 1 year, Lunai Bioworks (LNAI) earnings per share (EPS) declined 8.8% a year and free cash flow grew 38.1% a year, with a 10-year average return on invested capital (ROIC) of -25.3%. LNAI stock trades at $1.09.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems.
Exhibit A Growth Dossier
| Metric | 10yr | 5yr | 1yr | Grade |
|---|---|---|---|---|
| Book Value/Share GrowthBV/S Still negative | — | — | -107.1% | F |
| EPS GrowthEPS Still negative | — | — | -8.8% | F |
| Revenue GrowthRevenue | — | — | — | N/A |
| Cash Flow GrowthCash Flow Improving, but still negative | — | — | 38.1% | C |
| ROICROIC | -25.3% | -25.3% | 165.9% | B+ |
Exhibit B Valuation Ledger
- Current EPS
- -$61.63
- Historical Avg P/E
- —
- Future P/E (used for sticker price)
- Projected EPS (10yr)
- Sticker Price (10yr)
- Price for 15% Annual Return
- Expected Annual Return
No card required. $5/month after the trial if you keep going.
Not investment advice — a structured read of historical fundamentals, not a forecast or recommendation. Always do your own research.
Exhibit C Raw Data (last 10 years)
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Book Value / ShareBV/S | $296.24 | $110.60 | $66.12 | $108.27 | -$10.35 | -$3.06 | |
| Basic EPSEPS | -$45.36 | -$172.80 | -$56.80 | -$72.80 | -$86.24 | -$61.63 | |
| RevenueRevenue | $0 | $0 | $0 | $0 | $0 | $20,942 | |
| Free Cash FlowCash Flow | $-20,659,610 | $-15,737,492 | $-11,804,323 | $-11,041,860 | $-7,874,647 | $-5,259,557 | |
| ROIC (%)ROIC | -12.4% | -145.8% | -74.0% | -60.1% | 165.9% | — |
The exact underlying data used to compute the growth rates and grades above. The highlighted TTM column is the trailing twelve months through the most recently reported quarter.
Ticker INVESTigator Price Target
LNAI Stock FAQ
How fast is Lunai Bioworks growing?
Annual growth rates for LNAI. EPS: -8.8% over 1 year. Free cash flow: 38.1% over 1 year. Book value per share: -107.1% over 1 year.
What is LNAI's ROIC?
Lunai Bioworks' return on invested capital (ROIC) was 165.9% in fiscal 2024. Its 10-year average ROIC is -25.3%. ROIC above 10% is generally a sign of a business with a durable competitive advantage.
What is LNAI's P/E ratio?
LNAI has no meaningful P/E ratio right now because its earnings are negative. Trailing earnings per share are -$61.63.
What is Lunai Bioworks' market cap and stock price?
LNAI last traded at $1.09 as of October 12, 2026. Its 52-week range is $0.88 to $13.28. Lunai Bioworks has a market cap of $4.9M.
Exhibit D Related Coverage
Similar Stocks
Data as of October 12, 2026. Findings are derived from historical fundamentals — not a forecast, not advice. Cross-examine before you invest.
Grades are produced by Ticker INVESTigator's own model from public financial data and are for informational and educational purposes only. They are not investment advice or a recommendation to buy or sell any security. Do your own research.